Does TLR4 activation by endotoxin and danger signals drive NF-κB–mediated cytokine release, myeloid activation, and higher CRP?

Toll-like receptor 4 (TLR4) acts as a crucial sentinel of the innate immune system, recognizing both external pathogens and internal cellular distress signals to coordinate the body's inflammatory response.

Molecular Mechanisms of TLR4 Activation

• Myddosome Assembly and NF-κB Translocation: Upon binding lipopolysaccharide (LPS) or damage-associated molecular patterns (DAMPs) such as S100A8/A9, TLR4 dimerizes and recruits the sorting adaptor TIRAP/Mal to bridge TLR4 to MyD88. This assembly recruits IRAK family kinases (IRAK4 and IRAK1/2) to form the Myddosome complex. Subsequent activation of the E3 ubiquitin ligase TRAF6 and the TAK1-TAB complex phosphorylates the IKK complex. This leads to IκBα degradation, allowing NF-κB to translocate into the nucleus.
• Pro-inflammatory Cytokine Synthesis: Once in the nucleus, NF-κB drives the transcription and systemic release of key pro-inflammatory cytokines, including TNF, IL-1β, and IL-6.

Myeloid Activation and Acute-Phase Response

• Myeloid Cell Activation: TLR4 serves as a primary driver of inflammatory activity in myeloid cells. In monocytes, TLR4 ligation triggers robust cytokine production, while in neutrophils, it promotes adhesion, reactive oxygen species (ROS) generation, and chemokine release.
• Hepatocyte CRP Synthesis: The downstream elevation of C-reactive protein (CRP) is mediated by the release of IL-6. Systemic IL-6 signals directly to hepatocytes in the liver, initiating the acute-phase response. This program upregulates the transcription and secretion of CRP, rendering it a highly reliable clinical marker of active TLR4-mediated inflammation.

Bottom line

• Bottom line: TLR4 activation by endotoxins or endogenous danger signals initiates a MyD88-dependent signaling cascade that drives myeloid cell activation and NF-κB-mediated cytokine release. The resulting secretion of IL-6 directly stimulates hepatocytes to produce and release C-reactive protein (CRP), making elevated CRP a direct downstream indicator of this active pathway.